COVAXIN phase II/III clinical trial approved for 2-18 years
BBIL had proposed to carry out Phase II/III clinical trial of Covaxin in the age group of 2 to 18 years
BBIL had proposed to carry out Phase II/III clinical trial of Covaxin in the age group of 2 to 18 years
BASF’s simulation technology optimizes loading behavior and enables metal replacement
Its core operating income was ¥147.6 billion
Net sales from continuing operations of $753 million, an increase of 10% compared with $687 million in the prior year period
Provide innovative, eco-friendly solutions and service packages for dealers to meet volatile organic compounds targets
The High Court of Mumbai has ruled in favour of Sadhana Nitro Chem in the writ petition that it filed against Cibil Transunion
The agreement will help ensure wider reach and access to patients in India
It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021
The additional allocation of Tocilizumab will ensure sufficient availability for COVID-19 patients and augment the government’s efforts to fight the pandemic
The INVANZ brand and generic market had U.S. sales of approximately US $205 million MAT for the most recent twelve months ending March 2021 according to IQVIA Health
Second quarter sales of $2.5 billion increased thirteen percent due to seven percent higher energy cost pass-through, four percent favorable currency
The Group will work to accelerate the creation and development of new businesses
MGC has been working on geothermal power generation, which generates less carbon dioxide (CO2) during power generation
Project to be conducted with University of Minnesota’s Forever Green Initiative to investigate pennycress oil in production of polyhydroxyalkanoate (PHA), a biodegradable plastic alternative
Closed $0.5 billion of asset sales, including non-core assets in the DJ Basin
Construction on the plant is expected to begin at the end of the year
The plasticizers, which are drop-in replacements for existing products, offer the identical performance of Eastman's legacy products but with 20%–59% recycled content
The Department of Pharma has allocated this drug amongst the states/UTs based on expected supply that will be available from May 10 to May 31, 2021
Favipiravir is close to Remdesivir, Remdesivir is used to treat moderate to severe cases while Favipiravir is used to treat mild to moderate cases
The company has managed to launch one product and got approvals for four more during the first four months
Subscribe To Our Newsletter & Stay Updated